Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …

Objective To undertake a multicentre epidemiological study reflecting acromegaly in Spain.
Design Voluntary reporting of data on patients with acromegaly to an online database, by the …

Objective The European Registry on Cushing's syndrome (ERCUSYN) is designed to
collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design and …

Context: Pegvisomant is a GH receptor antagonist. The ACROSTUDY is a global safety
surveillance study of long-term treatment of acromegaly with pegvisomant. Objective: The …

Surgery is the treatment of choice for many pituitary tumors; pituitary function may suffer
after operation, but relief of pressure on the normal pituitary may also favor postoperative …

Context: Pituitary adenomas and pheochromocytomas/paragangliomas (pheo/PGL) can occur
in the same patient or in the same family. Coexistence of the two diseases could be due to …

Objective: Although increased central fat mass is characteristic of active Cushing’s syndrome
(CS), little is known about body composition and secretion of adipokines after long-term …

Acromegaly is a chronic disease with an important impact on patients, Health Related Quality
of Life (HRQoL). The ability to effectively measure Health Related Quality of Life is central …

Background Cushing's syndrome (CS) is characterized by excessive exposure to cortisol,
and is associated with both metabolic and behavioral abnormalities. Symptoms improve …

Acromegaly Quality of Life Questionnaire (AcroQoL) is a new disease-generated quality of
life (QOL) questionnaire comprising 22 questions covering physical and psychological …